Megasphaera sp.

Information

Microbe Identification

Megasphaera sp.

Microbe id: PMDBM2021614
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Megasphaera sp. [2023260]
Taxonomy Genus: Megasphaera [906]
Taxonomy Family: Veillonellaceae [31977]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Megasphaera sp.

No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Megasphaera sp.


No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Megasphaera sp. distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Megasphaera sp. in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Megasphaera sp.

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Depression, Postpartum PRJNA637228🔗-3.6678497100363716S
Diabetes Mellitus, Type 2 PRJNA807457🔗3.1537753122073516S
Diabetes Mellitus, Type 2 PRJDB5860🔗4.0433900942474516S
Diabetes Mellitus, Type 2 PRJNA646010🔗4.6598048200578416S
Diabetes Mellitus, Type 2 PRJNA871997🔗4.707192226459616S
Liver Cirrhosis, Alcoholic PRJNA690835🔗3.6957575691983716S
Rett Syndrome PRJNA687633🔗3.7444451821537516S
Colorectal Neoplasms PRJNA284542🔗-3.7138327417962216S
Colorectal Neoplasms PRJEB53415🔗-3.700775712349616S
Colorectal Neoplasms PRJNA936589🔗-3.13682570409557mNGS
Colorectal Neoplasms PRJNA888860🔗3.2805362603581mNGS
Lupus Erythematosus, Systemic PRJEB55711🔗3.29473381174951mNGS
Diabetes Mellitus, Type 1 PRJNA601279🔗-3.4602110853549316S
Diabetes Mellitus, Type 1 PRJNA604850🔗-2.77125260933061mNGS
Hepatitis, Autoimmune PRJNA556801🔗4.0032747139140216S
Colitis, Ulcerative PRJNA398089🔗-2.74385644919066mNGS
Carcinoma, Hepatocellular PRJNA932948🔗3.4359195716015mNGS
Metabolic Syndrome PRJNA417579🔗-3.0010465172789416S
Hepatolenticular Degeneration PRJNA1038771🔗4.2189395131067616S
Osteoporosis PRJNA565497🔗3.2146519789115316S
Leukemia, Myeloid, Acute PRJNA813705🔗3.10884372735111mNGS
Crohn Disease PRJDB6133🔗-4.8294848412748116S
Crohn Disease PRJNA398089🔗-2.40522920311646mNGS
Crohn Disease PRJNA993675🔗3.57477834950123mNGS
Psoriasis PRJNA938297🔗3.03033167453115mNGS
Schistosomiasis haematobia PRJNA526732🔗3.6194444039032116S
Purpura, Thrombocytopenic, Idiopathic PRJNA858062🔗2.90219747424462mNGS
Purpura, Thrombocytopenic, Idiopathic PRJNA531564🔗4.1656480740800416S
Moyamoya Disease PRJNA917033🔗-3.6021714286854316S
Premenstrual Syndrome PRJDB13374🔗-4.1896466436749216S
Arthritis, Rheumatoid PRJNA896336🔗-2.94595218679063mNGS
Arthritis, Rheumatoid PRJNA786110🔗3.6289845886307216S
Fatigue Syndrome, Chronic PRJNA379741🔗-2.77104165939069mNGS
Cholangiocarcinoma PRJNA932948🔗3.21452220038679mNGS
Flatulence PRJNA206071🔗-2.7689205597101516S
Hepatitis C PRJNA1070593🔗-3.4412941713214116S
IgA Deficiency PRJNA967340🔗-3.7768845494478816S
Schistosomiasis japonica PRJNA625383🔗-3.5880723065384916S
Cystic Fibrosis PRJNA314903🔗4.25834987917441mNGS
HIV Infections PRJNA836336🔗3.61938883757023mNGS
HIV Infections PRJDB11949🔗3.8220820810675216S
Autism Spectrum Disorder PRJNA917543🔗2.4676572051420416S
Autism Spectrum Disorder PRJEB42687🔗3.4648473229362316S
Hand, Foot and Mouth Disease PRJNA1017976🔗4.1990909700449716S
Mucocutaneous Lymph Node Syndrome PRJNA595748🔗-2.433495461844216S
Multiple Sclerosis PRJNA721421🔗-3.3669387458275216S
Amebiasis PRJNA608066🔗-5.0180715963296716S
COVID-19 PRJNA769052🔗-4.5881510251778616S
COVID-19 PRJNA689961🔗-3.61923909858313mNGS

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Megasphaera sp.



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Megasphaera sp.



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Megasphaera sp.

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Megasphaera sp.


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Megasphaera sp.



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Megasphaera sp.

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Megasphaera sp.

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Megasphaera sp.

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Megasphaera sp.



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Megasphaera sp.


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Megasphaera sp.


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?